您的位置: 首页 > 农业专利 > 详情页

N- (6- ( (2R,3S) -3,4-Dihydroxybutan-2-yloxy) -2- (4 - fluorobenzylthio) pyrimidin- 4 - yl) -3- methylazetidine- 1 - sulfonamide as chemokine receptor modulator
专利权人:
AstraZeneca AB
发明人:
Connolly, Stephen,Ebden, Mark Richard,Langer, Thomas,Steven, Alan Robert,Stewart, Craig Robert,Tomlin, Paula Margaret,Walters, Iain Alastair Stewart,Williams, Andrew John
申请号:
AU2012282316
公开号:
AU2012282316B2
申请日:
2012.07.10
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充